WILLIAM DEMANT/ADR (WILYY) Lowered to Sell at Zacks Investment Research

Share on StockTwits

Zacks Investment Research lowered shares of WILLIAM DEMANT/ADR (OTCMKTS:WILYY) from a hold rating to a sell rating in a research report report published on Wednesday.

According to Zacks, “William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Company focuses on three business areas: Hearing Devices, Diagnostic Instruments and Personal Communication. William Demant Holding A/S is headquartered in Smorum, Denmark. “

WILYY stock opened at $20.10 on Wednesday. WILLIAM DEMANT/ADR has a fifty-two week low of $13.47 and a fifty-two week high of $23.90. The company has a quick ratio of 0.70, a current ratio of 0.94 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $11.03 billion, a P/E ratio of 38.65, a price-to-earnings-growth ratio of 3.04 and a beta of 0.51.


William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.

Read More: Do Tariffs Work?

Get a free copy of the Zacks research report on WILLIAM DEMANT/ADR (WILYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for WILLIAM DEMANT/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WILLIAM DEMANT/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply